Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Okay. We'll go ahead and get started. I want to welcome everyone to the 2020 JPMorgan Health Care Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. Tessa Romero and Matt Bannon from the team are here as well. We're kicking off the conference with Agios, and presenting on behalf of the company is CEO, Jackie Fouse. Jackie?
Thank you, Anupam. Good morning, everybody. Thanks for -- happy New Year, first of all. Thanks for joining us this morning. We're quite honored to kick off this presentation stream for the 2020 JPM meeting this year.
And we're pretty excited about where we are as a company. After being around for 10-plus years, we see some clear inflection points coming for us in terms of where we can take our science and we look forward to sharing that with you today. That's why we want to put some stakes in the ground around our 2025 vision, and we'll also talk
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |